452 Preliminary analysis of a real-world study (RWS) of camrelizumab treatment in primary liver cancer (PLC)

• Zhendong Chen,
• Hong Qian,
• Nianfei Wang,
• Dayong Luo,
• Mu Yuan,
• Xinzhong Li,
• Qingsheng Kan,
• Erxuan Wang

Affiliations

Zhendong Chen

Oncology Department, The Second Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, China

Hong Qian

4 Centre for Health Evaluation and Outcomes Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Nianfei Wang

1The second Hospital of Anhui Medical University, Hefei, China

Dayong Luo

2The second people’s Hospital of Fuyang City, Fuyang, China

Mu Yuan

3The first affiliated Hospital of Bengbu Medical College, Bengbu, China

Xinzhong Li

4Huaibei people’s Hospital, Huaibei, China

Qingsheng Kan

7Suzhou Municipal Hospital of Anhui Province, Suzhou, China

Erxuan Wang

8Wangjiang County people’s Hospital, Anqing, China